Ra Capital Management as of Dec. 31, 2022
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 70 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A/s Sponsored Adr (ASND) | 17.2 | $850M | 7.0M | 122.13 | |
Vaxcyte (PCVX) | 5.7 | $281M | 5.9M | 47.95 | |
Aerovate Therapeutics (AVTE) | 4.9 | $242M | 8.3M | 29.30 | |
Dice Therapeutics | 4.3 | $214M | 6.8M | 31.20 | |
Verona Pharma Sponsored Ads (VRNA) | 3.3 | $165M | 6.3M | 26.13 | |
Rhythm Pharmaceuticals (RYTM) | 3.3 | $161M | 5.5M | 29.12 | |
Day One Biopharmaceuticals I (DAWN) | 3.1 | $152M | 7.0M | 21.52 | |
Vor Biopharma (VOR) | 3.1 | $151M | 23M | 6.65 | |
Biogen Idec (BIIB) | 3.0 | $148M | 533k | 276.92 | |
Cytek Biosciences (CTKB) | 2.8 | $137M | 13M | 10.21 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 2.5 | $122M | 2.4M | 49.92 | |
Avidity Biosciences Ord (RNA) | 2.5 | $121M | 5.5M | 22.19 | |
Wave Life Sciences SHS (WVE) | 2.4 | $120M | 17M | 7.00 | |
Janux Therapeutics (JANX) | 2.3 | $114M | 8.7M | 13.17 | |
89bio (ETNB) | 2.3 | $114M | 9.0M | 12.73 | |
Pepgen (PEPG) | 2.2 | $109M | 8.1M | 13.37 | |
ImmunoGen | 2.2 | $108M | 22M | 4.96 | |
Bellus Health Com New | 2.1 | $102M | 13M | 8.22 | |
Inhibrx | 1.9 | $95M | 3.9M | 24.64 | |
Celldex Therapeutics Com New (CLDX) | 1.9 | $93M | 2.1M | 44.57 | |
Iteos Therapeutics (ITOS) | 1.7 | $86M | 4.4M | 19.53 | |
Travere Therapeutics (TVTX) | 1.7 | $84M | 4.0M | 21.03 | |
Cogent Communications Hldgs Com New (COGT) | 1.4 | $69M | 6.0M | 11.56 | |
Aclaris Therapeutics (ACRS) | 1.4 | $69M | 4.4M | 15.75 | |
Fulcrum Therapeutics (FULC) | 1.4 | $69M | 9.5M | 7.28 | |
Acrivon Therapeutics Common Stock (ACRV) | 1.1 | $55M | 4.8M | 11.52 | |
Tyra Biosciences (TYRA) | 1.1 | $55M | 7.2M | 7.60 | |
Acumen Pharmaceuticals (ABOS) | 1.1 | $53M | 9.8M | 5.40 | |
Akero Therapeutics (AKRO) | 1.1 | $53M | 959k | 54.80 | |
Eliem Therapeutics (ELYM) | 1.0 | $48M | 13M | 3.67 | |
Gh Research Ordinary Shares (GHRS) | 1.0 | $48M | 4.9M | 9.72 | |
Icosavax | 1.0 | $47M | 6.0M | 7.94 | |
Rocket Pharmaceuticals (RCKT) | 1.0 | $47M | 2.4M | 19.57 | |
Nkarta (NKTX) | 0.9 | $47M | 7.8M | 5.99 | |
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.9 | $44M | 4.0M | 10.90 | |
Rxsight (RXST) | 0.8 | $39M | 3.1M | 12.67 | |
An2 Therapeutics (ANTX) | 0.7 | $36M | 3.8M | 9.53 | |
Alpine Immune Sciences | 0.7 | $32M | 4.4M | 7.35 | |
Geron Corporation (GERN) | 0.6 | $31M | 13M | 2.42 | |
Design Therapeutics (DSGN) | 0.6 | $31M | 3.0M | 10.26 | |
Hillevax (HLVX) | 0.6 | $29M | 1.8M | 16.73 | |
Kinnate Biopharma | 0.5 | $26M | 4.3M | 6.10 | |
Viridian Therapeutics Sponsored Ads (VRDN) | 0.5 | $26M | 880k | 29.21 | |
Silverback Therapeutics (SPRY) | 0.5 | $26M | 3.0M | 8.53 | |
Celcuity (CELC) | 0.4 | $20M | 1.4M | 14.01 | |
Solid Biosciences (SLDB) | 0.4 | $18M | 3.4M | 5.38 | |
Da32 Life Scnce Class A Com | 0.3 | $15M | 1.5M | 9.99 | |
Scpharmaceuticals (SCPH) | 0.3 | $13M | 1.9M | 7.17 | |
Imara | 0.3 | $13M | 3.3M | 4.09 | |
Tenaya Therapeutics (TNYA) | 0.2 | $12M | 6.1M | 2.01 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $12M | 3.4M | 3.50 | |
Arya Sciences Acquisitn Corp Class A Ord Shs | 0.2 | $10M | 1.0M | 10.09 | |
Werewolf Therapeutics (HOWL) | 0.2 | $8.8M | 4.3M | 2.05 | |
Aadi Bioscience (AADI) | 0.2 | $7.6M | 590k | 12.83 | |
Concert Pharmaceuticals I equity | 0.1 | $6.4M | 1.1M | 5.84 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $6.1M | 610k | 9.98 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.1 | $6.1M | 7.0M | 0.87 | |
Athira Pharma (ATHA) | 0.1 | $6.0M | 1.9M | 3.17 | |
Satsuma Pharmaceuticals Ord | 0.1 | $5.3M | 5.9M | 0.90 | |
CVRX (CVRX) | 0.1 | $5.0M | 275k | 18.35 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $4.7M | 2.6M | 1.80 | |
Dbv Technologies S A Sponsored Adr | 0.1 | $3.0M | 2.0M | 1.53 | |
Io Biotech (IOBT) | 0.1 | $2.6M | 1.1M | 2.30 | |
Third Harmonic Bio (THRD) | 0.0 | $2.3M | 535k | 4.30 | |
Fusion Pharmaceuticals | 0.0 | $2.1M | 660k | 3.15 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $1.4M | 1.6M | 0.90 | |
Nanostring Technologies (NSTGQ) | 0.0 | $1.1M | 144k | 7.97 | |
Immunic (IMUX) | 0.0 | $885k | 632k | 1.40 | |
Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $289k | 333k | 0.87 | |
Entera Bio SHS (ENTX) | 0.0 | $216k | 296k | 0.73 |